VolitionRx Ltd
VNRX
31 hedge funds and large institutions have $10.4M invested in VolitionRx Ltd in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 10 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0.02% more ownership
Funds ownership: 0.39% → 0.41% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 36 → 31 (-5)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
31% less capital invested
Capital invested by funds: $15M → $10.4M (-$4.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$609K |
| 2 |
Goldman Sachs
New York
|
+$223K |
| 3 |
Jane Street
New York
|
+$128K |
| 4 |
LIM
Lagoda Investment Management
New York
|
+$111K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$95.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$248K |
| 2 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$109K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$94K |
| 4 |
JP Morgan Chase
New York
|
-$83K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$58K |
VNRX Hedge Fund Activity: Q1 2020 in Review
31 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2020, worth a combined $10.4M — down 31% from $15M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of VNRX and 7 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $609K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $248K sold.
- 31 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2020, down from 36 in Q4 2019.
- Funds reported $10.4M of VolitionRx Ltd stock for Q1 2020, down 31% quarter-over-quarter.
- 7 funds opened new VolitionRx Ltd positions in Q1 2020 and 10 closed out, a net change of -3 holders.
- The largest VolitionRx Ltd buyer in Q1 2020 was Millennium Management, an estimated $609K added.
- The largest VolitionRx Ltd seller in Q1 2020 was Renaissance Technologies, an estimated $248K sold.
Based on aggregated 13F filings for Q1 2020.